USTEKINUMAB

103163 reported adverse events

Drug classes: Interleukin-12 Antagonist [EPC] Interleukin-23 Antagonist [EPC]

These side effects are most commonly reported by patients taking USTEKINUMAB:

# Side effect Count
0 DRUG INEFFECTIVE 14942
1 OFF LABEL USE 12880
2 PRODUCT DOSE OMISSION ISSUE 10242
3 FATIGUE 6966
4 PSORIASIS 6617
5 PAIN 6322
6 CROHN^S DISEASE 5993
7 ARTHRALGIA 5902
8 RASH 5714
9 PRODUCT USE ISSUE 5463
See all common reactions for USTEKINUMAB

USTEKINUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 414 0.6198
1 SWOLLEN JOINT COUNT INCREASED 1922 0.6021
2 RHEUMATIC FEVER 2543 0.5699
3 LUPUS VULGARIS 682 0.5413
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1066 0.5322
5 C-REACTIVE PROTEIN 492 0.5307
6 RHEUMATOID FACTOR POSITIVE 2982 0.5157
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3625 0.5054
8 FACET JOINT SYNDROME 1431 0.4391
9 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 883 0.4257
See all enriched reactions for USTEKINUMAB